Anesthesia CO2 Absorbent Market Analysis-Size, Share, Growth, Trends and Forecasts, 2015 To 2022: Grand View Research

Global Anesthesia CO2 Absorbent Market is expected to reach USD 79.1 million by 2022, according to a new report by Grand View Research, Inc. Rising geriatric population, increasing usage of regional anesthesia, and augmenting volume of surgical procedures across the globe are vital impact rendering drivers for the market. 

Anesthesia CO₂ absorbent forms a niche segment within the anesthesia disposables, the demand for which is expected to rise with increasing number of surgeries. According to the statistics provided by the WHO in collaboration with the Department of Health Policy and Management of Harvard, the global surgical volume is high and accounts for about 234 million surgeries per year. 

Furthermore, with this increase, a proportional rise in complications and deaths after surgery are being witnessed. According to the statistics provided by the U.S. Agency for Healthcare Research and Quality, one in 150 patients dies due to improper administration of anesthesia. 

The Harvard School of Public Health’s study links economic conditions of a country with volume of surgeries and states that prevalence of major surgeries is 37 times higher in countries with healthcare expenditure above USD 1,000 per person. 

 

Request to Sample of This Report @  http://www.grandviewresearch.com/industry-analysis/anesthesia-co2-absorbent-market

Further key findings from the study suggest:

• Amsorb is expected to witness the fastest growth over the forecast period owing to increasing demand for absorbents free from presence of KOH and clarity in exhaustion indication. Amsorb is anticipated to grow at a CAGR of over 10.0% over the next seven years and contribute about 14.0% revenue to the industry.

• Latin America and Asia Pacific are predicted to be the fastest growing regions for the anesthesia CO₂ absorbent market. Together, they are expected to hold over 25.0% of the market share by 2022. Strategic reforms in healthcare policies and increasing healthcare spending patterns are expected to be the market drivers within the region.

• Key players of the industry include GE Healthcare, Smiths Medical, CareFusion (Becton Dickinson and Co.), Armstrong Medical, and Drager Medical GmbH. Other players include King Pharmaceuticals, Allied Healthcare Products, Molecular Products, Micropore, and Medisize. GE Healthcare’s vital sign division responsible for manufacturing of anesthesia CO₂ absorbent was acquired by CareFusion in 2013, thereby making it a leader for single patient use consumables for anesthesiology.

• Also, cases of patent infringement are being reported by players such as Drager. In October 2015, the company filed a patent infringement lawsuit against Allied Healthcare alleging infringement carbolyme single use carbon dioxide absorption cartridges. This action is anticipated to help the company maintain its market share and control competition.

To Get Sample Copy of Report visit @ http://www.grandviewresearch.com/industry-analysis/anesthesia-co2-absorbent-market/request

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Information, Visit Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com

Blog Site: http://marketresearchandconsultingreport.blogspot.in/

Thermoplastic Polyurethane (TPU) Films Market Analysis-Size, Share, Growth, Trends and Forecasts To 2020: Grand View Research

The global TPU films market is expected to reach USD 724.6 million by 2020, according to a new study by Grand View Research, Inc. Automotive applications dominated the TPU films market, with demand estimated at 11,622.1 tons in 2013. Increasing use of TPU films in automotive applications such as paint protection, scratch protection, anti-chipping and rear bumper protection coupled with growing after sales market is expected to fuel market growth.

Asia Pacific emerged as the largest regional TPU films market, with demand estimated at 16,299 tons in 2013. Growth of automotive industry coupled with increasing application of TPU films in sports goods and construction is expected to drive the market growth over the next six years, at an estimated CAGR of 7.8% from 2014 to 2020. Furthermore, lower TPU film prices in Asia Pacific compared to other regional markets may also complement market growth.

 

Request to Sample of This Report @ http://www.grandviewresearch.com/industry-analysis/tpu-films-industry

Further key findings from the study suggest:

• Global TPU films market demand was 46,769.1 tons in 2013 and is expected to reach 68,033.1 tons by 2020, growing at a CAGR of 5.5% from 2014 to 2020.

• Aerospace is expected to be the fastest growing application segment, at an estimated CAGR of 6.6% from 2014 to 2020.

• North America and Europe accounted for over 27% and 19% of the total market volume in 2013, respectively. Increasing use of TPU films in automotive and construction applications is expected to drive the market growth in these regions.

• China and India dominated the TPU films market in Asia Pacific and accounted for over 60% of the market volume in 2013.

• Japan TPU films demand was estimated at 3,685.4 tons in 2013 and is expected to grow at an estimated CAGR of 4.9% from 2014 to 2020.

• The global TPU films market is highly fragmented with the top four companies including Bayer Material Science, Huntsman, 3M and Permali Gloucester Limited, accounting for just over 40% of the market in 2013. Other companies in the market include American Polyfilm Inc., PAR Group, Nippon, Lubrizol and Avery Dennison.

To Get Sample Copy of Report visit @ http://www.grandviewresearch.com/industry-analysis/tpu-films-industry/request

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Information, Visit Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com

Blog Site: http://marketresearchandconsultingreport.blogspot.in/

Post-marketing Pharmacovigilance and Medical Information Size, Share, Growth, Trends From 2012 To 2022: Grand View Research

Global post-marketing pharmacovigilance and medical information market is expected to reach USD 5.3 Billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of Adverse Drug Reactions (ADRs) coupled with incorporation of advanced ADR reporting tools is responsible for the overall growth of the post-marketing pharmacovigilance and medical information market. Increased drug consumption can be attributed to rising prevalence of chronic diseases such as tuberculosis that involve multiple drug regimes. 

Rising government initiatives for improvement of pharmacovigilance services and maintenance of medical databases are also responsible for inducing overall growth of post-marketing pharmacovigilance and medical information market. For instance, in December 2015, the USAID Systems for Improved Access to Pharmaceuticals and Services (SIAPS) launched PViMS tool to improve drug safety monitoring in low and middle income countries by helping clinicians, researchers, and regulatory authorities to collect, analyze, and monitor ADRs. 

 

Request to Sample of This Report @ http://www.grandviewresearch.com/industry-analysis/post-marketing-pharmacovigilance-medical-information-market

Further key findings from the study suggest:

• Spontaneous reporting dominated the post-marketing pharmacovigilance market in terms of revenue share as of 2014 and accounted for over 30.0% of market owing to wide usage in reporting of unknown and suspected ADRs. Preference of healthcare professionals and researchers towards this method is also responsible for the overall growth of this segment. 

• Cohort event monitoring is anticipated to be the fastest growing in post-marketing pharmacovigilance owing to application in all types of clinical events. Moreover, associated benefits such as early detection, high accuracy, and cost-efficiency are also anticipated to be the growth inducing factors. 

• Books dominated the overall product segment in terms of revenue share as of 2014 owing to the preference by clinicians and healthcare professionals as a primary source of information pertaining to adverse drug reactions. Online media is anticipated to be the fastest growing segment with a CAGR of over 13.0 % during the forecast period owing to rising inclination towards digitalized data. 

• Hospitals held the dominant share of end-use segment as a consequence of low costs associated with hospital based post-marketing pharmacovigilance surveillance. Research organizations segment is anticipated to show significant growth rate in coming years owing to streamlining of R&D in developing of new medicines and improving risk management through early prognosis of ADRs. 

• The key players of post-marketing pharmacovigilance and medical information market include Accenture Plc., Clinquest Group B.V., Cognizant Technology Solutions Corporation, Covance, Inc., iMEDGlobal Corporation, inVentiv Health Clinical, Parexel International Corporation, Pharmaceutical Product Development, Inc., PRA Health Sciences, Inc., Quintiles, F. Hoffmann-La Roche Ltd., Sanofi Aventis, Synowledge LLC, Wipro Ltd., ArisGlobal, Ergomed Plc. Rising strategic alliances and mergers &acquisitions are also anticipated to drive market growth. For instance, in January 2016, strategic collaboration of Parexel and Optum for reducingcosts related to post-approval studies and spreading awareness among the population base. 

To Get Sample Copy of Report visit @ http://www.grandviewresearch.com/industry-analysis/post-marketing-pharmacovigilance-medical-information-market/request

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Information, Visit Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com

Blog Site: http://marketresearchandconsultingreport.blogspot.in/